SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
BioMidwest
Humanetics Corporation Receives Funding from NIAID to Test Drug in COVID-19 Patients
July 23, 2020
 · 
4 min read
BioMidwest
Humanetics Corporation to Present Clinical Trial Results at the Annual Meeting of the American Society for Radiation Oncology
May 28, 2020
 · 
2 min read
Business
Dr. Colin Chinn, Former Joint Staff Surgeon, Joins Humanetics Medical Advisory Board
May 6, 2020
 · 
1 min read
Business
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug
February 19, 2020
 · 
1 min read
BioMidwest
ONL Therapeutics Announces First Patient Treated in Phase I Study with ONL1204ONL Therapeutics transformed into a clinical stage biopharmaceutical company with first-in-human study
October 23, 2019
 · 
3 min read
BioMidwest
U.S. Department of Defense Awards $6 Million to Humanetics Corporation for Advanced Development of Radioprotectant
October 1, 2019
 · 
3 min read
BioMidwest
Humanetics Corporation to Present at the Annual Meeting of the American Society for Radiation Oncology
October 23, 2018
 · 
2 min read
BioMidwest
Humanetics Corporation Presents Data on New Drug to Prevent Radiation Injury
September 26, 2018
 · 
1 min read
BioMidwest
Humanetics Awarded Patent for Oral Drug to Protect Warfighters and First Responders from Radiation Exposure
July 17, 2018
 · 
2 min read
Business
Humanetics Corporation Awarded Federal Grant for Development of New Radiation Countermeasure to Protect the Lungs
April 12, 2018
 · 
2 min read
Load More
JOBS